Alixia

Alixia is developing innovative compounds designed to target the complex tumor ecosystem, specifically addressing the underlying causes of cancer drug resistance. Their approach focuses on disrupting the metabolic and inflammatory processes within both cancerous and quasi-cancerous cells residing in the tumor microenvironment. By influencing multiple cell types within this environment, Alixia aims to create more effective and durable cancer treatments, ultimately improving patient outcomes and transforming the landscape of cancer therapy.